Document Detail


Healthcare costs around the time of smoking cessation.
MedLine Citation:
PMID:  22608375     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The Affordable Care Act mandates that new insurance plans cover smoking-cessation therapy without cost-sharing. Previous cost difference estimates, which show a spike around the time of cessation, suggest premiums might rise as a result of covering these services.
PURPOSE: The goal of the study was to test (1) whether individuals in an RCT of pharmacotherapy and counseling for smoking cessation differed in their healthcare costs around the cessation period, and (2) whether the healthcare costs of those in the trial who successfully quit were different from a matched sample of smokers in the community.
METHODS: Generalized linear regression models were used to analyze healthcare cost data on individuals enrolled in a comparative effectiveness trial of cessation therapies between October 2005 and May 2007 (1346 total participants; 1338 with requisite data for further analysis). Cost differences for the period preceding and subsequent to the cessation attempt were assessed by trial participants' 12-month sustained quit status. Healthcare cost differences between sustained quitters and a sample of community-dwelling smokers, matched to these quitters on the basis of health services use around the time trial participant enrolled and by demographics, were also examined. Data were analyzed in 2011.
RESULTS: All three groups had a spike in cost associated with the index clinic visit. Regression results revealed little difference in healthcare costs by quit status for trial participants until the sixth quarter post-quit. By that quarter, continuous sustained quitters cost $541 (p<0.001) less than continuing smokers. Continuous sustained quitters cost less than their matched community- dwelling smokers in almost every quarter observed. The cost difference ranged from $270 (p=0.01) during the quarter of quit, to $490 (p<0.01) in the 6th quarter after quitting.
CONCLUSIONS: The inclusion of smoking-cessation therapy does not appear to raise short-term healthcare costs. By the sixth quarter post-quit, sustained quitters were less costly than trial participants who continued smoking.
Authors:
Jason M Hockenberry; Susan J Curry; Paul A Fishman; Timothy B Baker; David L Fraser; Ron A Cisler; Thomas C Jackson; Michael C Fiore
Related Documents :
22578995 - The nist radioactivity measurement assurance program for the radiopharmaceutical industry.
18392925 - How well do return-to-work interventions for musculoskeletal conditions address the mul...
22458195 - Examples and suggestions for the control of paratuberculosis in european cattle.
22054625 - Psychobiological changes from relaxation response elicitation: long-term practitioners ...
17642635 - Recent advances in the control programs and therapy of leprosy.
22189985 - Professional development is enhanced by serving as a mini-cex preceptor.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  American journal of preventive medicine     Volume:  42     ISSN:  1873-2607     ISO Abbreviation:  Am J Prev Med     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-05-21     Completed Date:  2012-09-26     Revised Date:  2013-06-24    
Medline Journal Info:
Nlm Unique ID:  8704773     Medline TA:  Am J Prev Med     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  596-601     Citation Subset:  IM    
Copyright Information:
Published by Elsevier Inc.
Affiliation:
Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA. jason.hockenberry@emory.edu
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00296647
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Female
Health Care Costs / trends*
Health Care Surveys
Humans
Insurance Coverage
Logistic Models
Male
Middle Aged
Patient Protection and Affordable Care Act
Smoking Cessation / economics*
United States
Wisconsin
Young Adult
Grant Support
ID/Acronym/Agency:
P50 DA019706/DA/NIDA NIH HHS; P50 DA019706-100002/DA/NIDA NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Medicaid coverage and utilization of covered tobacco-cessation treatments: the arkansas experience.
Next Document:  Vaccine policy and arkansas childhood immunization exemptions: a multi-year review.